Remove Pharmaceutical Remove Planning Remove Valuation
article thumbnail

The Difference Makers: Key Person(s) Valuation

Musings on Markets

Of course, and with small businesses, especially those built around personal services (a doctor or plumber’s practice), it is part of the valuation process, where the key person is valued or at least priced and incorporated into valuation. To estimate key person value, there are three general approaches: 1.

Valuation 116
article thumbnail

Musings on Markets: META Lesson 3: Tell me a story!

CFO News Room

As someone who has spent the last four decades talking, teaching and doing valuation that we have lost our way in valuation. Even as data has become more accessible and our tools have become more powerful, it is my belief that the quality of valuations has degraded over time.

Marketing 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Apple’s Long Strange Trip to A $2T Valuation

PYMNTS

Apple is on the cusp of a stock market first — becoming the first public company in history to capture a $2 trillion valuation. Apple slashed 70 percent of its product plans, launching the “Think Different” ad campaign and executed a very, very bold vision from its new/old leader. So, will Apple make it to a $2 trillion valuation?

article thumbnail

META Lesson 3: Tell me a story!

Musings on Markets

Narrative and Value As someone who has spent the last four decades talking, teaching and doing valuation that we have lost our way in valuation. Even as data has become more accessible and our tools have become more powerful, it is my belief that the quality of valuations has degraded over time.

article thumbnail

Musings on Markets: META Lesson 2: Accounting Inconsistencies and Consequences

CFO News Room

That skewing can affect valuation and pricing judgments about these firms, and correcting accounting inconsistencies is a key step towards leveling the playing field. I believe it is, since failure to do so can have both valuation and pricing consequences.

article thumbnail

Invisible, yet Invaluable: Valuing Intangibles in the Birkenstock IPO!

Musings on Markets

The resulting debate among accountants about how to bring intangibles on to the books has spilled over into valuation practice, and many appraisers and analysts are wrongly, in my view, letting the accounting debate affect how they value companies.

Valuation 106
article thumbnail

The Frightful Five: Monster Valuation

PYMNTS

One Wall Street analyst speculates Amazon plans to not only get into the pharmaceuticals market, but the professional medical device market as well. However, the simultaneous launch of the company’s B2B medical device page could suggest Amazon has other plans. Paging Dr. Bezos!